Risk of Hematologic Malignancies in Patients With Acute Myocardial Infarction
Patients with AMI had a higher risk of hematologic malignancies than those without AMI. These findings suggest an association between AMI and hematologic malignancies, and underscore the importance of considering hematologic malignancy development in patients with AMI.
Authors
- Jon Suh
- Duk Won Bang (ORCID: https://orcid.org/0000-0002-6691-7546)
- Seong Soon Kwon (ORCID: https://orcid.org/0000-0001-6516-3220)
- Seug Yun Yoon (ORCID: https://orcid.org/0000-0001-8228-0218)
- Hoseob Kim (ORCID: https://orcid.org/0000-0003-3063-8024)
- Inki Moon (ORCID: https://orcid.org/0000-0002-3404-3012)
- Byoung-Won Park (ORCID: https://orcid.org/0000-0001-6986-2803)
- Nam-Su Lee (ORCID: https://orcid.org/0000-0002-0772-8702)
- Kyoung Ha Kim (ORCID: https://orcid.org/0000-0001-8842-4761)
- Min-Young Lee (ORCID: https://orcid.org/0000-0002-5873-1098)
- Mi‐Na Kim (ORCID: https://orcid.org/0000-0001-6589-5122)
- Sun Young Jeong (ORCID: https://orcid.org/0000-0001-5277-2254)
- Jong-Ho Won (ORCID: https://orcid.org/0000-0001-6176-1442)
Institutions
- Soonchunhyang University (KR)
- Soonchunhyang University Hospital Seoul (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
- Bucheon University (KR)
Publication Details
- Journal
- JACC CardioOncology
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1016/j.jaccao.2025.04.003
- Citations
- 2
- Primary Topic
- Chronic Myeloid Leukemia Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.54
Funders
- Korean Society of Cardiology
- Soonchunhyang University